Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Camcevi® (leuprolide) – New drug approval
May 26, 2021 - Foresee Pharmaceuticals announced the FDA approval of Camcevi (leuprolide), for the treatment of adult patients with advanced prostate cancer.
